-
1
-
-
67649579669
-
Updated clinical classification of pulmonary hypertension
-
Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54 (Suppl):S43-54.
-
(2009)
J Am Coll Cardiol
, vol.54
, Issue.SUPPL.
-
-
Simonneau, G.1
Robbins, I.M.2
Beghetti, M.3
-
2
-
-
70049112901
-
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
-
Galiè N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
-
(2009)
Eur Heart J
, vol.30
, pp. 2493-2537
-
-
Galiè, N.1
Hoeper, M.M.2
Humbert, M.3
-
3
-
-
85031205853
-
-
(Evian, France, September 6-10, 1998). The World Health Organization publication via the Internet. Available at
-
Rich S, Rubin LJ, Abenhail L et al: Executive summary from the World Symposium on Primary Pulmonary Hypertension (Evian, France, September 6-10, 1998). The World Health Organization publication via the Internet. Available at: http://www.who.int/ncd/cvd/pph.html.
-
Executive summary from the World Symposium on Primary Pulmonary Hypertension
-
-
Rich, S.1
Rubin, L.J.2
Abenhail, L.3
-
4
-
-
70449228209
-
The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects
-
Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
-
(1958)
Circulation
, vol.18
, pp. 533-547
-
-
Heath, D.1
Edwards, J.E.2
-
6
-
-
0033817459
-
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
-
The International PPH Consortium
-
The International PPH Consortium. Lane KB, Machado RD et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-4.
-
(2000)
Nat Genet
, vol.26
, pp. 81-84
-
-
Lane, K.B.1
Machado, R.D.2
-
7
-
-
0035797556
-
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
-
Trembath RC, Thomson JR, Machado RD et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
-
(2001)
N Engl J Med
, vol.345
, pp. 325-334
-
-
Trembath, R.C.1
Thomson, J.R.2
Machado, R.D.3
-
8
-
-
29144536869
-
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
-
Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 3792-3800
-
-
Hachulla, E.1
Gressin, V.2
Guillevin, L.3
-
9
-
-
0142187600
-
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach
-
Mukerjee D, St George D, Coleiro B et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1088-1093
-
-
Mukerjee, D.1
St George, D.2
Coleiro, B.3
-
10
-
-
33749329543
-
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
-
Fisher MR, Mathai SC, Champion HC et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54:3043-50.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3043-3050
-
-
Fisher, M.R.1
Mathai, S.C.2
Champion, H.C.3
-
11
-
-
33845498354
-
Portopulmonary hypertension: Results from a 10-year screening algorithm
-
Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology 2006;44:1502-10.
-
(2006)
Hepatology
, vol.44
, pp. 1502-1510
-
-
Krowka, M.J.1
Swanson, K.L.2
Frantz, R.P.3
McGoon, M.D.4
Wiesner, R.H.5
-
12
-
-
0031844681
-
Pulmonary vascular disorders in portal hypertension
-
Hervé P, Lebrec D, Brenot F et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998;11: 1153-66.
-
(1998)
Eur Respir J
, vol.11
, pp. 1153-1166
-
-
Hervé, P.1
Lebrec, D.2
Brenot, F.3
-
13
-
-
0023473478
-
Coexistent pulmonary and portal hypertension: Morphologic and clinical features
-
Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykoski RK, Edwards JE. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 1987;10:1233-8.
-
(1987)
J Am Coll Cardiol
, vol.10
, pp. 1233-1238
-
-
Edwards, B.S.1
Weir, E.K.2
Edwards, W.D.3
Ludwig, J.4
Dykoski, R.K.5
Edwards, J.E.6
-
14
-
-
43749107536
-
Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome
-
Galie N, Manes A, Palazzini M et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008;68:1049-66.
-
(2008)
Drugs
, vol.68
, pp. 1049-1066
-
-
Galie, N.1
Manes, A.2
Palazzini, M.3
-
16
-
-
0035165175
-
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
-
Ghio S, Gavazzi A, Campana C et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J AmColl Cardiol 2001;37:183-8.
-
(2001)
J AmColl Cardiol
, vol.37
, pp. 183-188
-
-
Ghio, S.1
Gavazzi, A.2
Campana, C.3
-
17
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
-
(2006)
Chest
, vol.129
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
Ahmad, S.4
Shorr, A.F.5
-
18
-
-
26844449508
-
Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity
-
Cottin V, Nunes H, Brillet PY et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-93.
-
(2005)
Eur Respir J
, vol.26
, pp. 586-593
-
-
Cottin, V.1
Nunes, H.2
Brillet, P.Y.3
-
19
-
-
0026542289
-
Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment
-
Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992;5: 334-42.
-
(1992)
Eur Respir J
, vol.5
, pp. 334-342
-
-
Moser, K.M.1
Auger, W.R.2
Fedullo, P.F.3
Jamieson, S.W.4
-
20
-
-
0021964278
-
Perfusion lung scanning: Differentiation of primary from thromboembolic pulmonary hypertension
-
Lisbona R, Kreisman H, Novales-Diaz J, Derbekyan V. Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. AJR Am J Roentgenol 1985;144:27-30.
-
(1985)
AJR Am J Roentgenol
, vol.144
, pp. 27-30
-
-
Lisbona, R.1
Kreisman, H.2
Novales-Diaz, J.3
Derbekyan, V.4
-
21
-
-
0026632785
-
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
-
Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
-
(1992)
N Engl J Med
, vol.327
, pp. 76-81
-
-
Rich, S.1
Kaufmann, E.2
Levy, P.S.3
-
22
-
-
20544448927
-
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
-
Sitbon O, Humbert M, Jaïs X et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-11.
-
(2005)
Circulation
, vol.111
, pp. 3105-3111
-
-
Sitbon, O.1
Humbert, M.2
Jaïs, X.3
-
23
-
-
13844280943
-
Survival with first-line bosentan in patients with primary pulmonary hypertension
-
McLaughlin VV, Sitbon O, Badesch DB et al. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005;25:244-9.
-
(2005)
Eur Respir J
, vol.25
, pp. 244-249
-
-
McLaughlin, V.V.1
Sitbon, O.2
Badesch, D.B.3
-
24
-
-
46449124591
-
Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2
-
Galiè N, Olschewski H, Oudiz RJ et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008;117: 3010-9.
-
(2008)
Circulation
, vol.117
, pp. 3010-3019
-
-
Galiè, N.1
Olschewski, H.2
Oudiz, R.J.3
-
25
-
-
26444534291
-
Sildenafil citrate therapy for pulmonary arterial hypertension
-
Galiè N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-57.
-
(2005)
N Engl J Med
, vol.353
, pp. 2148-2157
-
-
Galiè, N.1
Ghofrani, H.A.2
Torbicki, A.3
-
26
-
-
67649523052
-
Tadalafil therapy for pulmonary arterial hypertension
-
Galiè N, Brundage BH, Ghofrani HA et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009; 119:2894-903.
-
(2009)
Circulation
, vol.119
, pp. 2894-2903
-
-
Galiè, N.1
Brundage, B.H.2
Ghofrani, H.A.3
-
27
-
-
0036569119
-
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial
-
Galiè N, Humbert M, Vachiéry JL et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002;39:1496-502.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 1496-1502
-
-
Galiè, N.1
Humbert, M.2
Vachiéry, J.L.3
-
28
-
-
0030031888
-
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group
-
Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334:296-302.
-
(1996)
N Engl J Med
, vol.334
, pp. 296-302
-
-
Barst, R.J.1
Rubin, L.J.2
Long, W.A.3
-
29
-
-
39749156384
-
Immunosuppressive therapy in lupus-and mixed connective tissue diseaseassociated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases
-
Jais X, Launay D, Yaici A et al. Immunosuppressive therapy in lupus-and mixed connective tissue diseaseassociated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58:521-31.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 521-531
-
-
Jais, X.1
Launay, D.2
Yaici, A.3
|